CVSICV Sciences, Inc.
- Market cap
- $2.26M
- as of 2026-10-23
- Latest close
- $0.01
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Drug Manufacturers - Specialty & Generic
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2024-06-24
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Cheever Charlie E III | Aug 7 | Sep 9 | P | 94,854 | $0.02 | Purchase +$1,897 | 26,648,711 | No | Form 4 |
| Cheever Charlie E III | Aug 4 | Sep 9 | P | 108,000 | $0.02 | Purchase +$2,160 | 26,553,857 | No | Form 4 |
| Cheever Charlie E III | Jul 31 | Sep 9 | P | 1,730,000 | $0.02 | Purchase +$34,600 | 26,445,857 | No | Form 4 |
| Cheever Charlie E III | Jul 29 | Sep 9 | P | 60,000 | $0.02 | Purchase +$1,200 | 24,715,857 | No | Form 4 |
| Cheever Charlie E III | Jul 28 | Sep 9 | P | 1,830,000 | $0.02 | Purchase +$36,600 | 24,655,857 | No | Form 4 |
| Cheever Charlie E III | Jul 24 | Sep 9 | P | 470,075 | $0.02 | Purchase +$9,402 | 22,825,857 | No | Form 4 |
| Cheever Charlie E III | Jul 22 | Sep 9 | P | 272,500 | $0.02 | Purchase +$5,450 | 22,355,782 | No | Form 4 |
| Cheever Charlie E III | Jul 21 | Sep 9 | P | 335,000 | $0.02 | Purchase +$6,700 | 22,083,282 | No | Form 4 |
| Cheever Charlie E III | Jul 17 | Sep 9 | P | 749,000 | $0.02 | Purchase +$14,980 | 21,748,282 | No | Form 4 |
| Cheever Charlie E III | Jul 16 | Sep 9 | P | 91,387 | $0.02 | Purchase +$1,828 | 20,999,282 | No | Form 4 |
| McCorkle William | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 500,000 | $0.04 | $20,000 | 500,000 | No | Form 4 |
| Dowling Joseph DChief Executive Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 3,000,000 | $0.04 | $120,000 | 3,000,000 | No | Form 4 |
| Grasser JoergChief Financial Officer | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 2,350,000 | $0.04 | $94,000 | 2,350,000 | No | Form 4 |
| Corroon James Michael Jr. | Feb 18, 2025 | Feb 20, 2025 | A · derivative | 500,000 | $0.04 | $20,000 | 500,000 | No | Form 4 |
| Dowling Joseph DChief Executive Officer | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 3,000,000 | $0.05 | $150,000 | 3,000,000 | No | Form 4 |
| Grasser JoergChief Financial Officer | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 2,350,000 | $0.05 | $117,500 | 2,350,000 | No | Form 4 |
| Corroon James Michael Jr. | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 500,000 | $0.05 | $25,000 | 500,000 | No | Form 4 |
| McCorkle William | Jun 20, 2024 | Jun 24, 2024 | A · derivative | 500,000 | $0.05 | $25,000 | 500,000 | No | Form 4 |